Pneumonia News and Research

Latest Pneumonia News and Research

How gut microbes influence immune response to SARS-CoV-2

An article published in Critical Reviews in Food Science and Nutrition journal provides an overview of the role of gut microbiota in shaping the host immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Nov 2022

Experts highlight the need to study and develop treatments for fungal infections

Fungi in the soil cause a significant number of serious lung infections in 48 out of 50 states and the District of Columbia, including many areas long thought to be free of deadly environmental fungi, according to a study by researchers at Washington University School of Medicine in St. Louis.

17 Nov 2022

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Medicine and Mortality in Mali: one health heroine's work to improve community health

In this interview, we speak to Dr. Mariam Cissé about her recent Heroines of Health Award as well as her dedication to improving the health of her community.

From Women in Global Health 16 Nov 2022

One in four people with COPD waited more than five years for a diagnosis, research reveals

Asthma + Lung UK is calling for lung health to become an urgent priority after a damning report, released ahead of World COPD Day tomorrow, reveals that almost a quarter1 of people surveyed with the deadly lung disease chronic obstructive pulmonary disease (COPD), waited more than five years for a diagnosis, whilst one in eight waited more than a decade.

15 Nov 2022

Flu cases continue to rise throughout the U.S.

The rate of influenza cases throughout the U.S. continues to rise.

13 Nov 2022

World Pneumonia Day 2022: Pneumonia Affects Everyone

In commemoration of World Pneumonia Day 2022, we speak to Dr. Andy Whittamore, GP and Clinical Lead at Asthma + Lung UK, about the effect pneumonia can have on everyone.

13 Nov 2022

Sociability in monkeys associated with higher abundance of beneficial gut bacteria

Social connections are essential for good health and wellbeing in social animals, such as ourselves and other primates. There is also increasing evidence that the gut microbiome – through the so-called 'gut-brain axis' – plays a key role in our physical and mental health and that bacteria can be transmitted socially, for example through touch.

11 Nov 2022

Analysis reveals highest number of pneumonia deaths in the UK

More people die from pneumonia in the UK than anywhere else in Europe, according to new analysis by leading lung charity, Asthma + Lung UK. Now, the charity is raising awareness of the signs and symptoms of pneumonia, and urging people who are eligible, such as those with severe asthma, pulmonary fibrosis and COPD, to get their one-off pneumonia vaccine.

10 Nov 2022

Surge in RSV cases – how worried should you be?

RSV hospitalizations are reaching similarly high levels much earlier than normal this year.

10 Nov 2022

A knowledgebase of currently known categorized COVID-19 severity variants

In a recent study posted to the medRxiv* preprint server, researchers assessed human genome variants related to the susceptibility and severity of coronavirus disease 2019 (COVID-19).

10 Nov 2022

What is the role of adenoviruses in human health?

With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.

9 Nov 2022

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

8 Nov 2022

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Pneumonia News and Research

Latest Pneumonia News and Research

How gut microbes influence immune response to SARS-CoV-2

Experts highlight the need to study and develop treatments for fungal infections

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

Medicine and Mortality in Mali: one health heroine's work to improve community health

One in four people with COPD waited more than five years for a diagnosis, research reveals

Flu cases continue to rise throughout the U.S.

World Pneumonia Day 2022: Pneumonia Affects Everyone

Sociability in monkeys associated with higher abundance of beneficial gut bacteria

Analysis reveals highest number of pneumonia deaths in the UK

Surge in RSV cases – how worried should you be?

A knowledgebase of currently known categorized COVID-19 severity variants

What is the role of adenoviruses in human health?

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

Pioneering artificial intelligence could ease winter pressures on hospitals

Anti-herpes drug can fight against antibiotic-resistant bacterium

A review of vaccines against the respiratory syncytial virus

Study sheds light on how Gram-negative bacteria construct outer membrane to resemble body armor

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Medicare fines for high hospital readmissions drop, but 2,300 facilities are still penalized

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Pneumonia News and Research

Latest Pneumonia News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in